Accudata Solutions
- Company typePrivate
- Founded1991
- HeadquartersLafayette, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
Accudata Solutions firmographics
Firmographics- Name
- Accudata Solutions
- Legal name
- Accudata Solutions
- Website
- https://accudatasolutions.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Accudata Solutions industry classification
Industry- Product category
- Biostatistical Consulting Services
- NAICS
- Other Scientific and Technical Consulting Services (541690), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
- akta.pro secondary industry
- Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB)
Keywords
Where Accudata Solutions is headquartered
LocationHeadquarters
- HQ city
- Lafayette
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Accudata Solutions business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Biostatistical Consulting Services: Professional consulting services for clinical trial design, statistical analysis, and regulatory submissions for pharmaceutical, medical device, and biotech companies
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Consultation-based engagement |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Accudata Solutions product offering
Product offeringCore offering
Accudata Solutions provides biostatistical planning and analysis of clinical data for pharmaceutical, medical device, diagnostic, and biotechnology companies. The firm delivers four interconnected service modules: Clinical Trial Design (protocol development, sample size estimation, advanced adaptive/group sequential designs, IRB and regulatory negotiation), Biostatistical Analysis of Clinical Data (randomization schemes, CRF/eCRF design, edit checks, Tables Listings Figures, simulations, CRO oversight), Preclinical & Non-Clinical Statistics (animal studies, toxicology, assay development/validation), and Medical Device and Diagnostics (design verification/validation, reproducibility, diagnostic performance, calibration to reference standards). Services span regulatory pathways including 510(k), De Novo, LDT, PMA, NDA, and BLA submissions.
Product overview
Accudata Solutions is a biostatistical and clinical research consulting firm offering a unified portfolio of four interconnected service modules: Clinical Trial Design (protocol development and regulatory pathway navigation), Biostatistical Analysis of Clinical Data (data quality, analysis, and reporting), Preclinical & Non-Clinical Statistics (experimental design for non-clinical research), and Medical Device and Diagnostics (statistical support for 510(k), PMA, and other regulatory submissions). The firm specializes in serving small- to medium-sized pharmaceutical, medical device, diagnostic, and biotechnology companies with a personal, boutique-style approach to consulting.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 10 regulatory submissions including 4 PMA submissions, 1 NDA approval, and 1 510(k) approval
Companies that use Accudata Solutions
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
Accudata Solutions technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Accudata Solutions partnerships and signals
Strategic signalScale indicators3 records
Recent moves4 records
Expansion highlights2 records
Accudata Solutions competitors and assessment
Company assessmentDirect peers
- NAMSA: NAMSA is a medical device-focused CRO offering biostatistics, regulatory, and clinical study services for device manufacturers. It is a direct competitor in the medical device biostatistics and 510(k)/PMA submission segment where Accudata has notable experience.
- Clinipace Worldwide: Clinipace is a mid-sized CRO offering biostatistics, clinical operations, and regulatory services to small-to-mid-sized biotech and device sponsors. Its full-service model with a personal-relationship emphasis overlaps directly with Accudata's positioning.
- Rho: Rho is a contract research organization with deep biostatistics, data management, and clinical research services for FDA submissions across therapeutic areas. Its biostatistics-first identity and similar sponsor mix make it a direct peer to Accudata.
- Veristat: Veristat is a clinical research and biostatistics organization providing statistical analysis, clinical trial design, and regulatory submission support to small and mid-sized pharma, biotech, and medical device sponsors. It competes head-to-head with Accudata for biostatistics-led engagements from similar customer profiles.
- Premier Research: Premier Research is a mid-sized CRO with strong biostatistics, regulatory, and medical device capabilities serving small-to-mid pharma and device sponsors. It competes for the same boutique-style biostatistics engagements Accudata targets, particularly in rare disease and device trials.
- Cytel: Cytel is a specialized biostatistics and clinical data services firm offering statistical consulting, clinical trial design, and FSP services to pharma and biotech. It is the closest scaled competitor to Accudata's biostatistics-first niche, competing for the same small-to-mid biostatistics engagements.
Broad incumbents
- IQVIA: IQVIA is the largest global CRO and biostatistics provider with end-to-end clinical research and real-world evidence capabilities. While its scale is far beyond Accudata, it competes for biostatistics engagements whenever sponsors consolidate to a single full-service vendor.
- ICON plc: ICON is a global CRO offering biostatistics, data management, and full clinical trial services. Its biostatistics FSP and standalone statistical services compete with Accudata's offerings, particularly when sponsors seek a larger statistical team.
- Medpace: Medpace is a full-service CRO with strong biostatistics, clinical operations, and regulatory capabilities across pharma and medical device trials. While larger and broader than Accudata, it competes for the same small-to-mid biostatistics engagements when sponsors consolidate vendors.
- Pharmaceutical Product Development (PPD): PPD is a global CRO providing biostatistics, clinical operations, and laboratory services across all trial phases. Now part of Thermo Fisher, PPD competes with Accudata's small-to-mid biostatistics and regulatory submission work whenever sponsors consolidate statistical work with a single global vendor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights7 records
Customer concentration
Accudata Solutions social profiles
Digital presenceAccudata Solutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
Accudata Solutions leadership team
Management profileNumber of profiles
Profiles1 record
Accudata Solutions funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Accudata Solutions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Accudata Solutions
What does Accudata Solutions do?
Accudata Solutions provides biostatistical planning and analysis of clinical data for pharmaceutical, medical device, diagnostic, and biotechnology companies. The firm delivers four interconnected service modules: Clinical Trial Design (protocol development, sample size estimation, advanced adaptive/group sequential designs, IRB and regulatory negotiation), Biostatistical Analysis of Clinical Data (randomization schemes, CRF/eCRF design, edit checks, Tables Listings Figures, simulations, CRO oversight), Preclinical & Non-Clinical Statistics (animal studies, toxicology, assay development/validation), and Medical Device and Diagnostics (design verification/validation, reproducibility, diagnostic performance, calibration to reference standards). Services span regulatory pathways including 510(k), De Novo, LDT, PMA, NDA, and BLA submissions.
Is Accudata Solutions a public or private company?
Accudata Solutions is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Accudata Solutions founded?
Accudata Solutions was founded in 1991. It employs 1 to 10 people.
Where is Accudata Solutions based?
Accudata Solutions is headquartered in Lafayette, United States, in the North America region.
How does Accudata Solutions make money?
One revenue line is on record: biostatistical Consulting Services.
Who are Accudata Solutions's main competitors?
Direct peers on record are NAMSA, Clinipace Worldwide, Rho, Veristat, Premier Research and Cytel. Broad incumbents are IQVIA, ICON plc, Medpace and Pharmaceutical Product Development (PPD).
Does Accudata Solutions have an API?
No public API is recorded for Accudata Solutions.
What industry is Accudata Solutions in?
Accudata Solutions's product category is Biostatistical Consulting Services. Its primary akta.pro industry code is HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs, with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 541690 and its SIC code is 8731.